Minimally Invasive Surgery in Morbidly Obese Women

Obstet Gynecol. 2020 Jan;135(1):199-210. doi: 10.1097/AOG.0000000000003588.

Abstract

Minimally invasive gynecologic surgery provides a number of clinical advantages compared with open laparotomy. Over the past 25 years, important modifications and innovations have further expanded the utility of these techniques. Complications such as surgical site infection, venous thromboembolism, and wound cellulitis or dehiscence rise in concert with escalating obesity, so it stands to reason that these patients would derive the most benefit from minimally invasive surgery. Yet, surgical complexity also rises proportionally, requiring fastidious technique and allowing little margin for error. As nonsurgical interventions become more commonplace and the rate of morbid obesity continues to increase, those women actually requiring a gynecologic operation through an abdominal approach will be ever more likely to present a number of challenges to safe completion of minimally invasive surgery. This article frames the topic and offers some tips across the range of care to enhance the likelihood of achieving success in this patient population most in need of surgical expertise.

MeSH terms

  • Female
  • Gynecologic Surgical Procedures / methods*
  • Humans
  • Laparoscopy / methods*
  • Minimally Invasive Surgical Procedures / methods*
  • Obesity, Morbid*
  • Postoperative Complications*
  • Surgical Wound Infection
  • Venous Thromboembolism